Gene: ERGIC1
Official Full Name: endoplasmic reticulum-golgi intermediate compartment 1provided by HGNC
Gene Summary: This gene encodes a cycling membrane protein which is an endoplasmic reticulum-golgi intermediate compartment (ERGIC) protein which interacts with other members of this protein family to increase their turnover. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17914 | ERGIC1 Knockout cell line (HeLa) | Human | ERGIC1 | 1:3~1:6 | Negative | Online Inquiry |
KO17915 | ERGIC1 Knockout cell line (HCT 116) | Human | ERGIC1 | 1:2~1:4 | Negative | Online Inquiry |
KO17916 | ERGIC1 Knockout cell line (HEK293) | Human | ERGIC1 | 1:3~1:6 | Negative | Online Inquiry |
KO17917 | ERGIC1 Knockout cell line (A549) | Human | ERGIC1 | 1:3~1:4 | Negative | Online Inquiry |
ERGIC1 Gene Knockout Cell Lines are specialized cellular models designed to study the functional role of the ERGIC1 gene, which is crucial for various cellular processes including protein transport and membrane trafficking. By introducing targeted gene disruptions, these knockout cell lines provide researchers with a powerful tool to investigate the gene’s influence on cellular functions, mechanisms underlying diseases, and the broader implications of protein misfolding and trafficking dysregulation.
The key mechanism of action involves the generation of ERGIC1 knockout cells through CRISPR-Cas9 technology or similar gene-editing methods, resulting in the absence of ERGIC1 protein expression. This enables scientists to elucidate the specific contributions of the ERGIC1 gene to endoplasmic reticulum (ER)-Golgi transport pathways and its role in maintaining cellular homeostasis. Such insights are pivotal in unraveling associated pathologies, including neurodegenerative diseases and certain metabolic disorders.
In a research context, ERGIC1 Gene Knockout Cell Lines hold significant scientific importance. They are invaluable for high-throughput screening of potential therapeutic agents, understanding the molecular mechanisms behind protein trafficking disorders, and serving as model systems for studying cellular stress responses. Clinically, these models can provide a framework for developing innovative treatment strategies tailored to diseases related to the dysfunction of protein transport mechanisms.
Compared to alternative models, such as transient knockdown systems, the stability and longevity of ERGIC1 knockout cell lines allow for more reproducible experiments and long-term studies. Their precise genetic modifications ensure a clearer interpretation of data without the variability often associated with transient expression systems.
For researchers and clinicians alike, the value of these cell lines lies in their ability to provide robust, reliable data that can lead to new insights and advancements in both basic and applied bioscience. Our company specializes in the development and optimization of innovative biological products, emphasizing quality and reliability, which ensures that our ERGIC1 Gene Knockout Cell Lines meet the highest standards for research applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.